News and Insights of 3D Printing and Manufacturing
Two postdoctoral researchers at UC Santa Barbara, Renxuan Xie and Sanjoy Mukherjee, developed the first 3D-printable “bottlebrush” elastomer. The new material results in printed objects that have unusual softness and elasticity that closely resemble those of human tissue. The researchers’ findings were published in the journal Science Advances.
CollPlant Biotechnologies released a letter from its Chief Executive Officer, Yehiel Tal, to its shareholders. The letter summarizes a strong year for the company and its shareholders, which has benefitted from the uptick in 3D printing research and interest throughout 2020 to position itself for an even stronger 2021. The letter reads as follows:
3D-printed orthodontics have come a long way in the past three years, and Carbon and Candid’s new partnership to produce models for clear aligners that straighten teeth is grist for this mill. Carbon’s L1 printers and DLS process allow Candid to introduce Candid Pro, its “orthodontics-as-a-service” doctor-driven clear aligner therapy. This service offers customized, on-demand clear aligners designed specifically for dental and orthodontic practices. The entire service is delivered on Candid’s digital platform.
Once thought destined mainly for prototyping, additive manufacturing is now increasingly employed in the development of spare parts, small series production and tooling in forward-thinking manufacturing industries such as aerospace, electronics, automotive and medical devices. Among industries at the forefront of innovative manufacturing, the medical sector has emerged as a major segment driving the growth of additive manufacturing: France’s 3D MedLab operates at the forefront of this segment
nAngioDerm, a regenerative medicine project partnered with Microlight3D, a French ultra-high-resolution 3D printer manufacturer, has received funding in the amount of €747,000 to aid the healing of wounds from ulcers or major burns.
FabRx, a British 3D printed pharmaceuticals company, has developed personalized medicine for children with the rare metabolic disorder, maple syrup urine disease (MSUD).
Merck, the global pharmaceutical company, has announced plans to work with AMCM, an EOS Group company that builds custom additive manufacturing machines. The two companies will work on developing and producing 3D printed tablets, first for clinical trials, then later for commercial manufacturing.
Chinese 3D printing technology startup Triastek has raised $15 million in Series A funding to accelerate the research and development of its 3D printed drugs.